| 1. Accepted major perpetrators | 2. Rejected perpetrators | 3. Unclassifiable | 4. Full table |
conivaptan is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP3A.
|Not available in Australia or New Zealand||armodafinil|
Footnotes and References
|a.||systemic preparations not available in Australia or New Zealand.|
DisclaimerWARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy. Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.